Approval · Notice of Compliance 26736 · 2021
TRODELVY: Notice of Compliance 26736
Issued September 24, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26736
- Date
- September 24, 2021
- Company
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRODELVY | 02520788 | Marketed |
Medicinal ingredients
- SACITUZUMAB GOVITECAN 180 MG per VIAL